Salarius Pharmaceuticals Stock Price on November 25, 2024
| SLRX Stock | USD 1.43 0.02 1.38% |
Below is the normalized historical share price chart for Salarius Pharmaceuticals extending back to January 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Salarius Pharmaceuticals stands at 1.43, as last reported on the 30th of November, with the highest price reaching 1.51 and the lowest price hitting 1.42 during the day.
If you're considering investing in Salarius Stock, it is important to understand the factors that can impact its price. At this stage we consider Salarius Stock to be dangerous. Salarius Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0122, which indicates the firm had a 0.0122% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Salarius Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Salarius Pharmaceuticals' Risk Adjusted Performance of 0.0028, variance of 30.46, and Coefficient Of Variation of (13,223) to confirm if the risk estimate we provide is consistent with the expected return of 0.0667%.
At this time, Salarius Pharmaceuticals' Other Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 3.4 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 5 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 14.21 in 2024, whereas Price To Sales Ratio is likely to drop 97.37 in 2024. Salarius Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2015 | 200 Day MA 2.8696 | 50 Day MA 1.5387 | Beta 0.932 |
Salarius |
Sharpe Ratio = 0.0122
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | SLRX | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.44 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Salarius Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Salarius Pharmaceuticals by adding Salarius Pharmaceuticals to a well-diversified portfolio.
Price Book 0.7145 | Enterprise Value Ebitda 1.5245 | Price Sales 18.1198 | Shares Float 1.4 M | Wall Street Target Price 26 |
Related Headline
SAB Biotherapeutics Headline on 25th of November 2024
Acquisition by Hamilton Christine E of 82987 shares of SAB B... by MacroaxisInsider
Filed transaction by SAB Biotherapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Salarius Pharmaceuticals Valuation on November 25, 2024
It is possible to determine the worth of Salarius Pharmaceuticals on a given historical date. On November 25, 2024 Salarius was worth 1.37 at the beginning of the trading date compared to the closed value of 1.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Salarius Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Salarius Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Salarius Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Salarius Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 1.42 | 1.44 | 1.37 | 1.37 | 16,922 | |
11/25/2024 | 1.37 | 1.60 | 1.36 | 1.52 | 47,272 |
| 1.55 | 1.55 | 1.48 | 1.52 | 5,741 |
| Backtest Salarius Pharmaceuticals | | | Salarius Pharmaceuticals History | | | Salarius Pharmaceuticals Valuation | Previous | Next |
Salarius Pharmaceuticals Trading Date Momentum on November 25, 2024
| On November 26 2024 Salarius Pharmaceuticals was traded for 1.52 at the closing time. The top price for the day was 1.55 and the lowest listed price was 1.48 . The trading volume for the day was 5.7 K. The trading history from November 26, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 0.66% . |
Salarius Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Salarius Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Salarius Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Salarius financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Salarius Pharmaceuticals Stock history
Salarius Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Salarius is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Salarius Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Salarius Pharmaceuticals stock prices may prove useful in developing a viable investing in Salarius Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.3 M | 3.4 M | |
| Net Loss | -28.4 M | -27 M |
Salarius Pharmaceuticals Quarterly Net Working Capital |
|
Salarius Pharmaceuticals Stock Technical Analysis
Salarius Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Salarius Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Salarius Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Salarius Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Salarius Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Salarius Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Salarius Pharmaceuticals stock market strength indicators, traders can identify Salarius Pharmaceuticals entry and exit signals to maximize returns
Salarius Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Salarius Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Salarius Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Salarius to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0028 | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.97) | |||
| Treynor Ratio | (0.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Salarius Stock Analysis
When running Salarius Pharmaceuticals' price analysis, check to measure Salarius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Salarius Pharmaceuticals is operating at the current time. Most of Salarius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Salarius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Salarius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Salarius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.